Want to see RLMD full AI Analyst Report?
ETFs with Relmada Therapeutics (RLMD) Exposure
The following ETFs maintain exposure to Relmada Therapeutics (RLMD). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
29 ETFs Hold Relmada Therapeutics (RLMD)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in RLMD |
|---|---|---|---|---|---|---|
| PSIL | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | 4.74% | $2.21M | 0.60% |
| XPH | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | 0.86% | $3.90M | 1.06% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.42% | $143.86K | 0.04% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 0.25% | $463.99K | 0.12% |
| FSEG | Fidelity Enhanced Small Cap Growth ETF | $7.92M | 0.28% | 0.11% | $8,727.28 | <0.01% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.08% | $989.30K | 0.27% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | 0.02% | $251.77K | 0.07% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.02% | $381.57K | 0.09% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.02% | $3.15M | 0.82% |
| FESM | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | 0.01% | $977.68K | 0.27% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.01% | $1,760.59 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.01% | $2.07M | 0.52% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.01% | $568.48K | 0.15% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.01% | $161.01K | 0.04% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.01% | $34.57K | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.01% | $8.22M | 2.24% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.01% | $18.36K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $106.64 | <0.01% |
| PRFZ | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | <0.01% | $239.33K | 0.06% |
| AVSC | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | <0.01% | $285.44K | 0.08% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $4.16M | 1.03% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | <0.01% | $934.22K | 0.23% |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | <0.01% | $16.40K | <0.01% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $395.6 | <0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | <0.01% | $568.98K | 0.16% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $11.95M | 2.97% |
| IWV | iShares Russell 3000 ETF | $20.56B | 0.20% | <0.01% | $105.26K | 0.03% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $29.49K | <0.01% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $7,148.32 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in RLMD |
|---|---|---|---|---|---|---|
| PSIL | 4.74% | AdvisorShares Psychedelics ETF | $46.62M | 1.00% | $2.21M | 0.60% |
| XPH | 0.86% | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | $3.90M | 1.06% |
| BBC | 0.42% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $143.86K | 0.04% |
| SBIO | 0.25% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $463.99K | 0.12% |
| FSEG | 0.11% | Fidelity Enhanced Small Cap Growth ETF | $7.92M | 0.28% | $8,727.28 | <0.01% |
| IWC | 0.08% | iShares Micro-Cap ETF | $1.26B | 0.60% | $989.30K | 0.27% |
| GSSC | 0.02% | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | $251.77K | 0.07% |
| VTWG | 0.02% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $381.57K | 0.09% |
| IWO | 0.02% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $3.15M | 0.82% |
| FESM | 0.01% | Fidelity Enhanced Small Cap ETF | $6.85B | 0.28% | $977.68K | 0.27% |
| VRSD | 0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $1,760.59 | <0.01% |
| VTWO | 0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $2.07M | 0.52% |
| R2EH | 0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $568.48K | 0.15% |
| RSSL | 0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $161.01K | 0.04% |
| RTYS | 0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $34.57K | <0.01% |
| IWM | 0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $8.22M | 2.24% |
| ITWO | 0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $18.36K | <0.01% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $106.64 | <0.01% |
| PRFZ | <0.01% | Invesco FTSE RAFI US 1500 Small-Mid ETF | $2.71B | 0.36% | $239.33K | 0.06% |
| AVSC | <0.01% | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | $285.44K | 0.08% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $4.16M | 1.03% |
| VHT | <0.01% | Vanguard Health Care ETF | $20.70B | 0.09% | $934.22K | 0.23% |
| MSSM | <0.01% | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | $16.40K | <0.01% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $395.6 | <0.01% |
| ITOT | <0.01% | iShares Core S&P Total U.S. Stock Market ETF | $97.26B | 0.03% | $568.98K | 0.16% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $11.95M | 2.97% |
| IWV | <0.01% | iShares Russell 3000 ETF | $20.56B | 0.20% | $105.26K | 0.03% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $29.49K | <0.01% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $7,148.32 | <0.01% |
Popular ETF Comparisons
RLMD ETF Exposure FAQ
What ETFs hold Relmada Therapeutics stock?
Relmada Therapeutics (RLMD) is currently held by 29 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to RLMD include SPDR (XPH), iShares (IWO) and AdvisorShares (PSIL).
Which ETF has the largest exposure to RLMD?
The ETF with the largest exposure to RLMD is SPDR (XPH), with approximately $3.90M in market value exposure.
How much RLMD stock is held by ETFs?
ETFs currently hold approximately $12.48M worth of Relmada Therapeutics (RLMD) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.